NCT05232838 - US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 20, 2022

Primary Completion Date

June 15, 2025

Study Completion Date

June 30, 2030

Conditions

Hydrocephalus, Normal PressureHydrocephalus

Interventions

DEVICE

eShunt Implant

The eShunt System is intended to shunt cerebrospinal fluid from the intracranial subarachnoid space to the venous system for the treatment of patients with normal pressure hydrocephalus, reducing disability due to symptoms including one or more of gait disturbance, cognitive dysfunction and urinary incontinence.

Trial Locations (11)

10016

NYU Langone Health, New York

10467

Montefiore Medical Center, The Bronx

14203

University at Buffalo,, Buffalo

14642

University of Rochester Medical Center, Rochester

23219

Virginia Commonwealth University, Richmond

32207

Baptist Health, Jacksonville

40506

University of Kentucky Research Foundation, Lexington

66160

University of Kansas Medical Center, Kansas City

06511

Yale University, New Haven

02215

Beth Israel Deaconess Medical Center, Boston

02903

Rhode Island Hospital, Providence